The increase in an antigen-experienced subset of B cells, called aged B cells (ABCs) in the spleen 3 0 3 of aged mice has been attributed to chronic levels of toll-like receptor and B cell receptor signaling (Hao 3 0 4 et al., 2011; Rubtsova et al., 2015; Russell Knode et al., 2017) . Given the similarity of adipose B cells to 3 0 5 ABCs ( Figure S1H ), the ability of adipose to drive ABC formation ( Figure S1I ) and the dependency on 3 0 6 the Nlrp3 inflammasome for adipose B cell expansion ( Figure 2B ), we wondered whether the age-related 3 0 7 increase in splenic ABCs requires Nlrp3 inflammasome. Quantification of CD21 -
CD23
-B cells in the 3 0 8 spleen of 3 month or 24 month old wild-type and Nlrp3-deficient mice revealed significant elevation in 3 0 9 the frequency of ABCs in the 24 month old wild-type mice that was less pronounced in the 24 month old 3 1 0 Nlrp3-deficient mice ( Figure 3A ). We identified a corresponding age-regulated decrease in marginal zone 3 1 1 and follicular B cells that was not restored with Nlrp3-deficiency ( Figure 3B ), suggesting that the Nlrp3 3 1 2 inflammasome is required for age-related ABC expansion, but not marginal or follicular B cell alterations. 3 1 3
Long-lived mice with reduced growth hormone (GH) signaling have improved insulin sensitivity 3 1 6 and reduced Nlrp3 inflammasome activation (Spadaro et al., 2016) . To address whether longevity is 3 1 7 associated with ABCs and visceral adipose B cell expansion in aging, we aged growth hormone receptor 3 1 8 (GHR)-sufficient and GHR-knockout (GHRKO) mice to 20 months of age. Along with their extended 3 1 9 lifespan and increased insulin sensitivity (Coschigano et al., 2003; Masternak and Bartke, 2012) , GHRKO 3 2 0 mice have lower body weight, reduced visceral adipose tissue weight and decreased adipose cellularity 3 2 1 ( Figure S3A ). Quantification of ABCs in wild-type or GHRKO spleens revealed significant decreases in 3 2 2 the percentage and total number of ABCs ( Figure 3C ). Furthermore, the visceral adipose tissue of 3 2 3 GHRKO mice had significantly reduced percentage of B220 + cells, but not CD4 + T cells ( Figure 3D ). 3 2 4
These data highlight that reduction of ABCs is associated with extended lifespan and may be related to 3 2 5 improved metabolic outcomes associated with longevity. 3 2 6 3 2 7
Depletion of adipose B cells restores insulin sensitivity of aged mice 3 2 8
As the age-related expansion in adipose B cells is localized to visceral adipose and not to other 3 2 9 adipose tissues depots ( Figure 1D ), we first wanted to determine whether a reduction in visceral adipose 3 3 0 tissue B cell numbers would restore age-related insulin resistance. We devised an intra-adipose injection 3 3 1 protocol allowing for adipose tissue-specific depletion of adipose B cells ( Figure S4A ) to avoid systemic 3 3 2 depletion of B cells. Body-weight and visceral adipose tissue weight in ISO-treated and mCD20 mAb-3 3 3 treated mice were comparable (figure S4B&C). At 30 days after intra-adipose injection with CD20 mAb, 3 3 4 B cells were specifically reduced in visceral, but not in subcutaneous adipose tissue, spleen, bone marrow 3 3 5 or peritoneal cavity ( Figure 4A & 4C, S4D ). When challenged with insulin, 20 month old wild-type mice 3 3 6
given the intra-adipose injection with CD20 mAb showed improved insulin tolerance as compared to the 3 3 7 20 month old wild-type mice given an ISO control injection ( Figure 4C ). As improvements in insulin 3 3 8 sensitivity suggested that lipolytic capacity of aged-adipose may also be improved, we fasted the intra-3 3 9 adipose injected mice to induce lipolysis, a process that can be measured by release of glycerol from 3 4 0 adipose tissue (Schweiger et al., 2014) . However, there were no differences in glycerol release from thefed ( Figure 4D ) or fasted ( Figure 4E) To further examine the contribution of both age-expanded ABCs in lymphoid tissues and adipose 3 4 8 B cells in metabolic dysregulation, we performed intraperitoneal (i.p.) injection of the ISO or CD20 mAb 3 4 9 into 21month old mice to systemically deplete all B cells ( Figure S4E ). As expected, ip injection of CD20 3 5 0 mAb reduced the percentage of B cells in the spleen and visceral adipose tissue in the 21month old mice 3 5 1 ( Figure 4F ). FALCs tended to appear smaller and show reduced staining for B220 ( Figure 4G ) and 3 5 2 percentages of ABCs in the spleen were significantly reduced with CD20 mAb treatment ( Figure 4H ).
5 3
To address whether B cell depletion could restore age-related alterations in immune cell 3 5 4 composition, we quantified the percentage of total CD4 + T cells, as well as, the PD1 + effector population 3 5 5
and Treg cells. There was an increase in the frequency of total CD4 + cells ( Figure 4I ) in the B cell 3 5 6 depleted mice, but there was a statistically significant visceral adipose-specific reduction in the Treg and 3 5 7
+ sub-populations (Figure 4I, S4H and S4I) . These data indicate that although a single CD20 3 5 8 mAb injection to deplete B cells does not reduce CD4 + T cell frequency, the CD4 + T cell subsets are more 3 5 9 similar to subsets of CD4 + T cells from young adipose. 3 6 0 Consistent with previous findings showing restored insulin tolerance in obese mice depleted of B 3 6 1 cells and in aged mice depleted of Tregs (Bapat et al., 2015; Winer et al., 2011) , 20 month old B cell-3 6 2 depleted mice had improved insulin sensitivity ( Figure S4J and S4K). To address whether systemic 3 6 3 depletion of B cells could restore lipolytic signaling and metabolic substrate availability in aged mice, 22 3 6 4 month old mice given an intraperitoneal injection of ISO antibody or CD20 mAb were fasted for 24hours.
6 5
The adipocyte lipases, adipose triglyceride lipase (ATGL) and hormone sensitive lipase (HSL) are (Camell et al., 2017) . As compared to the ISO treated aged wild-type mice, CD20mAB treatment resulted 3 6 8 in increased levels of phosphorylated HSL and total ATGL during fasting, indicating that the age-related 3 6 9 reduction in lipolytic signaling was restored with B cell depletion ( Figure 4J ). Consistent with improved 3 7 0 lipolytic capability, the visceral adipose tissue from mice given CD20mAB also had increased 3 7 1 isopreteronol-stimulated lipolysis ( Figure S4L ). Given that white adipose lipolysis is required for the 3 7 2 generation of metabolic substrates to induce thermogenesis and protect against cold stress (Schreiber et 3 7 3 al., 2017; Shin et al., 2017) and aged mice have impaired maintenance of core body temperature during 3 7 4 cold stress ( Figure S4M ) (Berry et al., 2017) , we wanted to test whether B cell depletion would improve 3 7 5 age-induced defense against cold stress. Consistent with the restored lipolysis providing additional 3 7 6 metabolic substrates, 20 month old B cell-depleted mice were able to maintain core body temperature 3 7 7 when placed at four degrees C ( Figure 4K ). Taken together these data implicate the Nlrp3 inflammasome-3 7 8
induced inflammation and B cell expansion in as mechanisms that contribute towards impaired lipolytic 3 7 9 capacity of visceral adipose tissue and inability to defend against cold stress in aging. immune cell responses, and increased risk for autoimmunity (Ghosh et al., 2014) . Given that visceral 4 1 3 adipose B cell expansion occurs between 10 and 15 months, which is prior to splenic ABC expansion, but 4 1 4 follows decreases in adipose tissue macrophages, CD4 + T cell expansion and ovarian failure in female 4 1 5 mice (Diaz Brinton, 2012; Gosden et al., 1983; Hao et al., 2011) , it is interesting to speculate on potential 4 1 6 multiple causal factors of these associated events. Our B cell depletion experiments suggest a direct link 4 1 7 between B cell expansion and T cell subset accumulation ( Figure 4I ). Endogenous sex hormones 4 1 8 influence both adaptive and innate immunity and a direct link with the Nlrp3 inflammasome has not been 4 1 9
reported. 4 2 0
Lymphatic vessels maintain fluid balance and regulate transport of antigen and immune cells 4 2 1 (Ruddle, 2016); however they have also been implicated in driving adipogenesis, adiposity and insulin 4 2 2 resistance (Harvey et al., 2005) . Ours study identified HEVs and lymphatic vessels within FALCs, 4 2 3 suggesting regulated trafficking of lymphocytes. However, given previous findings describing the loss of 4 2 4 functionality in lymphatic vessels and increased permeability in aging (Zolla et al., 2015) , lymphatic 4 2 5 vessels may also feed-forward into chronic age-related inflammation. FALC numbers are reduced in the 4 2 6 aged Nlrp3-deficient mice, yet still contain lymphatic vessels; whether improved functionality of 4 2 7 lymphatic vessels contributes to improved metabolic capacity remains to be tested.
2 8
Together, these data show a role for B cell depletion in restoring adipose tissue immune cell 4 2 9 compartments, as well as metabolic and immunologic capacity. Importantly, our data reveal previously Buscher, K., Wang, H., Zhang, X., Striewski, P., Wirth, B., Saggu, G., Lutke-Enking, S., Mayadas, T.N., 4 9 5
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Wild-type; N=3 at each age; female mice 7 9 8
Experiment 4: Adipose depot comparisons of resident adipose B cells in 7m and 24m old female mice 7 9 9
Wild-type; N= 8 at 7m; N=7 at 24m; each pooled from multiple litters that were bred and housed 8 0 0
at Yale University; Female mice 8 0 1
Experiment 5: Quantification of visceral and subcutaneous lymphocyte infiltration 8 0 2
Wild-type; N= 8 at 3m and N =8 at 20m; Female mice 8 0 3
Experiment 6: Sorting of adipose tissue B cells for RNA sequencing analysis 8 0 4
Wild-type; N= 3 at 3m and N =2 at 24m pooled from 2 mice each* 8 0 5
Experiment 7: Ki67 expression in immune cells from aged animals (two individual cohorts compiled) 8 0 6
Wild-type; N=3 and N=4 at 24m in two individual cohorts 8 0 7
Experiment 8: Aging of reporter mice and wild-type mice for confocal analysis 8 0 8
Hec6ST-GFP mice N=3; ProxTom mice N=3; wild-type N=3; all 20-22m; female mice 8 0 9
Experiment 9: Aging of WT and Nlrp3-/-mice for adipose B and T cell quantification at 3m or 24m of 8 1 0 age 8 1 1 N = 3 WT at 3m; N= 5 Nlrp3-/-at 3m; N=7 WT at 24m; N=5 Nlrp3-/-at 24m pooled from two 8 1 2 separate experiments 8 1 3
Experiment 10: Aging of WT and Nlrp3-/-mice for FALC quantification and Prox1+ staining 8 1 4
N= 5/5 WT/Nlrp3-/-at 24m for FALC quantification. N= 3/3 WT/Nlrp3-/-at 24m; female mice 8 1 5
Experiment 11: Aging of WT and Nlrp3-/-mice for adipose B cell sorting 8 1 6 N=2 WT at 24m of age and N=3 Nlrp3-/-at 24m of age pooled from 2 mice each* 8 1 7
Experiment: 12: Aging of WT and Nlrp3-/-mice for quantification of adipose tissue B and T cells at 4m 8 1 8
and 10m of age. 8 1 9 N= 4; female mice at 4m WT, 10m WT and 10m Nlrp3-/-8 2 0
Experiment 13: Aging of WT and GHRKO mice for immune cell quantificationExperiment 14: Intra-adipose injection of CD20 mAB for visceral adipose-specific B cell depletion (two 8 2 3 individual cohorts) 8 2 4
N=7 ISO and N=7 CD20mAB; pooled from two separate experiments; female mice 8 2 5
Experiment 15: I.P. injection of CD20 mAB for systemic depletion of B cells for insulin tolerance test 8 2 6 N = 4 ISO and N= 5 CD20 mAB 8 2 7
Experiment 16: I.P. injection of CD20 mAB for systemic depletion of B cells with fasting challenge (two 8 2 8
individual cohorts) 8 2 9
N= 3 3m ISO; N= 3 22m ISO; N= 4 22m CD20 mAB; repeated twice; representative data shwon 8 3 0
Experiment 17: I.P injection of CD20 mAB for systemic depletion of B cells with cold challenge (three 8 3 1
individual cohorts compiled) 8 3 2 N= 6 3-8m ISO; N= 7 23m ISO; N=9 23m CD20m AB pooled together for rectal temperature (eBioscience) and intracellular antibodies using cytofix (eBioscience/ThermoFisher Western blot 8 5 7
Visceral adipose was snap frozen in liquid nitrogen immediately after harvest. Tissue was homogenized 8 5 8
in RIPA buffer containing protease inhibitors. Protein concentration was quantified using the DC protein 8 5 9
assay (Bio-Rad) and equal amounts of protein were run on an SDS-PAGE gel and transferred to 8 6 0 nitrocellulose membrane. Blots were probed with primary antibodies and then incubated in secondary 8 6 1 antibody of the appropriate species (ThermoFisher). Detection occurred using chemiluminescent 8 6 2 visualization (Fisher, Bio-rad). 8 6 3 8 6 4
Whole-mount staining 8 6 5
Staining was performed similar to those previously published. In brief, adipose tissue was collected, fixed 8 6 6
in 1% PFA and blocked with 5% BSA. Permeabilization was done using 0.1% Triton-X 100 in 5% BSA. 8 6 7
The adipose tissue was then stained in primary antibodies over 1-2 days and secondary antibody, if 8 6 8 needed, for 2.5 h in goat blocking serum. Confocal images were acquired using a laser scanning Leica 8 6 9 SP8 or Leica SP5 and analyzed using Leica Application Suite AF. 8 7 0
For FALC counting, Images were acquired on a Zeiss Inverted Microscope (Axio) or Keyence (BZ-8 7 1 X710) using the stitching function within. FALCs from each tissue were counted using CD3 + staining. 8 7 2
Histology and pathological analysis: Visceral and subcutaneous adipose tissues were fixed in 10% FoxP3-APC, Ki67-PECy7, CD19-FITC, B220-AF600, CD8-eF450, CD11b-FITC, MHCII-PECy7, B220-8 8 4 AF700, B220-eF450, CD25-PE, PD1-APC-e780, CD21/35-FITC, CD23-PE, CD23-eF450, F4/80-PE, 8 8 5
CD11b-PerCP-Cy5.5, CD3-eF450, B220-FITC, B220-PerCP-Cy5.5. 8 8 6
Intracellular staining: Intracellular antigens were detected using the eBioscience Fix/Perm nuclear 8 8 7 staining kit as instructed by manufacture-supplied protocol. 8 8 8
For whole mount staining, the following antibodies were used: DAPI, B220-APC, B220-PE, CD3-FITC, 8 8 9
Prox1 (Abcam; ab101851), Chicken anti-Rabbit-AF488 (Life Tech; A21441) 8 9 0
For western blot analysis, the following antibodies were used: pHSL (Ser563; 4139), HSL (4107), ATGL 8 9 1
(2439), Beta-Actin (4967) (Cell signaling). 
